CD4 and neoplasm: Once they reach the tumor microenvironment, neutrophils may undergo transition to MDSCs that inhibit CD4+ and CD8+ tumor-infiltrating lymphocytes, as well as stimulating tumor growth, angiogenesis and metastasis (61).